BioCentury | Feb 25, 2013
Company News

Chiesi, Cornerstone Therapeutics deal

...respiratory distress syndrome (RDS) in premature infants. Cornerstone was formed through the 2008 merger of Critical Therapeutics Inc....
BioCentury | Feb 21, 2013
Company News

Cornerstone receives proposal to go private

...respiratory distress syndrome (RDS) in premature infants. Cornerstone was formed through the 2008 merger of Critical Therapeutics Inc....
BioCentury | Mar 24, 2011
Targets & Mechanisms

Receptor strategy for brain ischemia

...previously licensed IP covering the use of nicotinic acetylcholine receptor agonists for inflammatory indications from Critical Therapeutics...
BioCentury | Nov 9, 2009
Finance

EPS Watch

...said reflected an increased sales and management team. Cornerstone was formed from the merger between Critical Therapeutics Inc....
...October 2008. Financial figures prior to merger reflect historical results of Cornerstone BioPharma, and not Critical Therapeutics...
BioCentury | May 18, 2009
Finance

Ebb & Flow

...late-stage development in the U.S. Cornerstone was formed last year through the reverse merger of Critical Therapeutics Inc....
...chronic bronchitis (ABECB), pharyngitis/tonsillitis and uncomplicated skin and skin-structure infections (SSSIs). The completion of the Critical Therapeutics...
BioCentury | May 8, 2009
Company News

Cornerstone to market Chiesi's Curosurf

...intends to market in the U.S. Cornerstone was formed last year through the merger of Critical Therapeutics Inc....
BioCentury | Nov 10, 2008
Company News

Cornerstone BioPharma Inc., Critical Therapeutics deal

...day before the deal closed (see BioCentury, May 5). Cornerstone BioPharma Inc. , Cary, N.C. Critical Therapeutics Inc....
BioCentury | May 12, 2008
Finance

Ebb & Flow

...approve, pushing shares up $0.11 to $1.47 on the week. Critical criticisms Respiratory disease company Critical Therapeutics...
BioCentury | May 5, 2008
Company News

Cornerstone BioPharma Inc., Critical Therapeutics deal

...Co. Inc. advised Cornerstone, and Lazard Ltd. advised Critical. Cornerstone BioPharma Inc. , Cary, N.C. Critical Therapeutics Inc....
BioCentury | Apr 14, 2008
Clinical News

R: Phase I data

...to prevent and treat asthma, comprises R(+) zileuton and its mirror image isomer S(-) zileuton. Critical Therapeutics Inc....
Items per page:
1 - 10 of 139
BioCentury | Feb 25, 2013
Company News

Chiesi, Cornerstone Therapeutics deal

...respiratory distress syndrome (RDS) in premature infants. Cornerstone was formed through the 2008 merger of Critical Therapeutics Inc....
BioCentury | Feb 21, 2013
Company News

Cornerstone receives proposal to go private

...respiratory distress syndrome (RDS) in premature infants. Cornerstone was formed through the 2008 merger of Critical Therapeutics Inc....
BioCentury | Mar 24, 2011
Targets & Mechanisms

Receptor strategy for brain ischemia

...previously licensed IP covering the use of nicotinic acetylcholine receptor agonists for inflammatory indications from Critical Therapeutics...
BioCentury | Nov 9, 2009
Finance

EPS Watch

...said reflected an increased sales and management team. Cornerstone was formed from the merger between Critical Therapeutics Inc....
...October 2008. Financial figures prior to merger reflect historical results of Cornerstone BioPharma, and not Critical Therapeutics...
BioCentury | May 18, 2009
Finance

Ebb & Flow

...late-stage development in the U.S. Cornerstone was formed last year through the reverse merger of Critical Therapeutics Inc....
...chronic bronchitis (ABECB), pharyngitis/tonsillitis and uncomplicated skin and skin-structure infections (SSSIs). The completion of the Critical Therapeutics...
BioCentury | May 8, 2009
Company News

Cornerstone to market Chiesi's Curosurf

...intends to market in the U.S. Cornerstone was formed last year through the merger of Critical Therapeutics Inc....
BioCentury | Nov 10, 2008
Company News

Cornerstone BioPharma Inc., Critical Therapeutics deal

...day before the deal closed (see BioCentury, May 5). Cornerstone BioPharma Inc. , Cary, N.C. Critical Therapeutics Inc....
BioCentury | May 12, 2008
Finance

Ebb & Flow

...approve, pushing shares up $0.11 to $1.47 on the week. Critical criticisms Respiratory disease company Critical Therapeutics...
BioCentury | May 5, 2008
Company News

Cornerstone BioPharma Inc., Critical Therapeutics deal

...Co. Inc. advised Cornerstone, and Lazard Ltd. advised Critical. Cornerstone BioPharma Inc. , Cary, N.C. Critical Therapeutics Inc....
BioCentury | Apr 14, 2008
Clinical News

R: Phase I data

...to prevent and treat asthma, comprises R(+) zileuton and its mirror image isomer S(-) zileuton. Critical Therapeutics Inc....
Items per page:
1 - 10 of 139